Cuatrecasas, G., De Cabo, F., Coves, M. J., Patrascioiu, I., Aguilar, G., Cuatrecasas, G., . . . Muñoz, E. (2024). Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-61590-6
Chicago Style (17th ed.) CitationCuatrecasas, Guillem, et al. "Dapagliflozin Added to Metformin Reduces Perirenal Fat Layer in Type 2 Diabetic Patients with Obesity." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-61590-6.
MLA (9th ed.) CitationCuatrecasas, Guillem, et al. "Dapagliflozin Added to Metformin Reduces Perirenal Fat Layer in Type 2 Diabetic Patients with Obesity." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-61590-6.